Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Banerji

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Cancer Letters|August 26, 1998
The field bean protease inhibitor has the potential to suppress B16F10 melanoma cell lung metastasis in miceA Banerji, A Fernandes, S Bane, et al.
Indian Journal of Experimental Biology|June 1, 1990
Toxicity of capillin, the insecticidal principle of Artemisia nilagirica ClarkeA Banerji, D L Luthria, S D Kokate
Life Sciences|November 24, 1980
Cyclo (His-Pro): a selective inhibitor of rat prolactin secretion in vitroC Prasad, J F Wilber, V Akerstrom, et al.
Diabetes|March 1, 1996
Long-term normoglycemic remission in black newly diagnosed NIDDM subjectsM A Banerji, R L Chaiken, H E Lebovitz
Diabetes|April 1, 1981
The mechanism of hyperchloremic acidosis during the recovery phase of diabetic ketoacidosisM S Oh, M A Banerji, H J Carroll
The Pediatric Infectious Disease Journal|October 1, 1995
Use of single dose ceftriaxone in the emergency department during an outbreak of serogroup C meningococcal diseaseA Banerji, W J King, N MacDonald, et al.
Diabetes Care|August 1, 1990
Characterization and significance of sulfonylurea receptorsL Siconolfi-Baez, M A Banerji, H E Lebovitz
Journal of the Indian Medical Association|April 16, 1970
Neurogenic arthropathies (Charcot's joints)P C Das, A Banerji, A Roy, et al.
Life Sciences|April 13, 1981
Alterations in hypothalamic-pituitary-thyroid regulation produced by diabetes mellitusJ F Wilber, A Banerji, C Prasad, et al.
Diabetes|April 1, 1995
Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatmentM A Banerji, R L Chaiken, H E Lebovitz
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Cancer Letters|August 26, 1998
The field bean protease inhibitor has the potential to suppress B16F10 melanoma cell lung metastasis in miceA Banerji, A Fernandes, S Bane, et al.
Indian Journal of Experimental Biology|June 1, 1990
Toxicity of capillin, the insecticidal principle of Artemisia nilagirica ClarkeA Banerji, D L Luthria, S D Kokate
Life Sciences|November 24, 1980
Cyclo (His-Pro): a selective inhibitor of rat prolactin secretion in vitroC Prasad, J F Wilber, V Akerstrom, et al.
Diabetes|March 1, 1996
Long-term normoglycemic remission in black newly diagnosed NIDDM subjectsM A Banerji, R L Chaiken, H E Lebovitz
Diabetes|April 1, 1981
The mechanism of hyperchloremic acidosis during the recovery phase of diabetic ketoacidosisM S Oh, M A Banerji, H J Carroll
The Pediatric Infectious Disease Journal|October 1, 1995
Use of single dose ceftriaxone in the emergency department during an outbreak of serogroup C meningococcal diseaseA Banerji, W J King, N MacDonald, et al.
Diabetes Care|August 1, 1990
Characterization and significance of sulfonylurea receptorsL Siconolfi-Baez, M A Banerji, H E Lebovitz
Journal of the Indian Medical Association|April 16, 1970
Neurogenic arthropathies (Charcot's joints)P C Das, A Banerji, A Roy, et al.
Life Sciences|April 13, 1981
Alterations in hypothalamic-pituitary-thyroid regulation produced by diabetes mellitusJ F Wilber, A Banerji, C Prasad, et al.
Diabetes|April 1, 1995
Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatmentM A Banerji, R L Chaiken, H E Lebovitz
Pageof 11